Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Scalp condition healed with prednisone and tacrolimus.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Belatacept may be a promising treatment for alopecia areata.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.